| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | IRONWOOD PHARMACEUTICALS INC COM CL A | 2,810,315 | 44,628,000 | 13.69% | ||
| 2 | GALAPAGOS NV | 500,576 | 32,367,000 | 9.93% | ||
| 3 | BRISTOL MYERS SQUIBB CO | 500,000 | 26,960,000 | 8.27% | Call | |
| 4 | ASSEMBLY BIOSCIENCES INC | 2,943,164 | 21,220,000 | 6.51% | ||
| 5 | DERMIRA INC | 522,000 | 17,654,000 | 5.42% | ||
| 6 | ARDELYX INC COM | 1,310,023 | 16,952,000 | 5.20% | ||
| 7 | KURA ONCOLOGY INC | 2,611,906 | 16,324,000 | 5.01% | ||
| 8 | FIVE PRIME THERAPEUTICS INC | 286,612 | 15,044,000 | 4.62% | ||
| 9 | FIBROGEN INC COM | 686,184 | 14,204,000 | 4.36% | ||
| 10 | GILEAD SCIENCES INC | 150,000 | 11,868,000 | 3.64% | Call | |
| 11 | ALLERGAN PLC | 50,000 | 11,516,000 | 3.53% | Call | |
| 12 | AGIOS PHARMACEUTICALS INC | 200,000 | 10,564,000 | 3.24% | ||
| 13 | PROTEOSTASIS THERAPEUTICS IN | 602,315 | 9,390,000 | 2.88% | ||
| 14 | EXACT SCIENCES CORP | 500,000 | 9,285,000 | 2.85% | Put | |
| 15 | ACHAOGEN INC COM | 1,679,707 | 8,046,000 | 2.47% | ||
| 16 | CYTOKINETICS INC | 846,654 | 7,772,000 | 2.38% | ||
| 17 | KINDRED BIOSCIENCES INC | 1,432,765 | 7,149,000 | 2.19% | ||
| 18 | Syndax Pharmaceuticals Inc | 357,365 | 5,418,000 | 1.66% | ||
| 19 | BEIGENE LTD | 163,470 | 5,037,000 | 1.55% | ||
| 20 | IRONWOOD PHARMACEUTICALS INC | 281,500 | 4,470,000 | 1.37% | Call | |
| 21 | Ascendis Pharma | 219,200 | 4,406,000 | 1.35% | ||
| 22 | SPARK THERAPEUTICS INC | 68,600 | 4,120,000 | 1.26% | ||
| 23 | ADVERUM BIOTECHNOLOGIES INC | 946,263 | 3,889,000 | 1.19% | ||
| 24 | Nabriva Therapeutics AG | 548,912 | 3,870,000 | 1.19% | ||
| 25 | INTELLIA THERAPEUTICS INC | 200,858 | 3,419,000 | 1.05% | ||
| 26 | CHIMERIX INC | 598,062 | 3,313,000 | 1.02% | ||
| 27 | ONCOMED PHARMACEUTICALS INC | 265,784 | 3,038,000 | 0.93% | ||
| 28 | FATE THERAPEUTICS INC COM | 590,527 | 1,842,000 | 0.57% | ||
| 29 | CHEMOCENTRYX INC | 178,000 | 1,075,000 | 0.33% | ||
| 30 | SYROS PHARMACEUTICALS INC | 63,596 | 882,000 | 0.27% | ||
| 31 | CASCADIAN THERAPEUTICS INC | 103,800 | 170,000 | 0.05% | Call |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001140361-16-086430, filed 2016.11.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
